top of page
This website is currently under development with limited functionalities. The comprehensive website will be available shortly. Any inconvenience is regretted.
Innovative. Transformative. Disruptive. Affordable.
GeneStore's ITDA strategy strives to enable ‘innovative’ in-vitro diagnostic (IVD) solutions for infectious diseases that bring about healthcare ‘transformations’ that are both ‘disruptive’ and ‘affordable’ from a global stand-point.
It is this strategy that is behind GeneStore's Disruption during the COVID-19 pandemic and flawless manufacturing experience of over 5 million kits manufactured.
bottom of page